Professor of Medicine and Physiology and Bipophysics, UAMS
Cardiology
Dr. Jawahar L. Mehta, MD
|
|
Give Review
Doctor Jawahar L. Mehta, MD works in the field of Cardiology. He went to medical school at Government Medical College Amritsar. He over the years received 2 awards: "Elected Member" and "Whos Who in Medicine and Healthcare". Jawahar L. Mehta, MD is a published doctor as well. He has 99 publications published. The latest was: LOX-1 in macrophage migration in response to ox-LDL and the involvement of calpains. He is registered with Medicare and accepts Medicare payments.
Publications
- LOX-1 in macrophage migration in response to ox-LDL and the involvement of calpains.
- Endothelin-1 upregulation mediates aging-related cardiac fibrosis.
- Hemodynamic shear stress modulates endothelial cell autophagy: Role of LOX-1.
- LOX-1 - dependent mitochondrial DNA damage and NLRP3 activation during systemic inflammation in mice.
- Optimal Blood Pressure in Patients With Atrial Fibrillation (from the AFFIRM Trial).
- Tobacco and Cardiovascular Health.
- LOX-1 Deletion Limits Cardiac Angiogenesis in Mice Given Angiotensin II.
- Contemporary trends of hospitalization for Atrial fibrillation in the United States, 2000 through 2010: implications for healthcare planning.
- Hypertension, TLR4 activation in brain and cardiac hypertrophy.
- Interaction of carbamylated LDL with LOX-1 in the induction of endothelial dysfunction and atherosclerosis.
- Prevention of export of anoxia/reoxygenation injury from ischemic to non-ischemic cardiomyocytes via inhibition of endocytosis.
- LOX-1, mtDNA damage and NLRP3 inflammasome Activation in Macrophages: Implications in Atherogenesis.
- GLP-1 Agonists Inhibit Ox-LDL Uptake in Macrophages by Activating Protein Kinase A.
- Can autologous bone marrow transplantation improve systolic function in patients with multiple myeloma related cardiac amyloidosis?
- The neighborhood where you live is a risk factor for stroke.
- Regulation of autophagy and apoptosis in response to angiotensin II in HL-1 cardiomyocytes.
- High Fat Diet Causes Renal Fibrosis in LDLr-null Mice via MAPK-NF-κB Pathway Mediated by Ox-LDL.
- Inflammation and Atherosclerosis--Revisited.
- LOX-1 deletion and macrophage trafficking in atherosclerosis.
- LOX-1, a bridge between GLP-1R and mitochondrial ROS generation in human vascular smooth muscle cells.
- Dipeptidyl peptidase-4 inhibitors in cardioprotection: a promising therapeutic approach.
- LOX-1 in the maintenance of cytoskeleton and proliferation in senescent cardiac fibroblasts.
- MicroRNAs involved in the regulation of postischemic cardiac fibrosis.
- Regulation of MSR-1 and CD36 in macrophages by LOX-1 mediated through PPAR-?.
- Aspirin inhibits oxidant stress, reduces age-associated functional declines, and extends lifespan of Caenorhabditis elegans.
- Oxidant stress in mitochondrial DNA damage, autophagy and inflammation in atherosclerosis.
- Regulation of autophagy and apoptosis in response to ox-LDL in vascular smooth muscle cells, and the modulatory effects of the microRNA hsa-let-7g.
- Lectin-like Oxidized Low-density Lipoprotein Receptor-1 (LOX-1) and Cardiac Fibroblast Growth.
- Atrial fibrillation following autologous stem cell transplantation in patients with multiple myeloma: incidence and risk factors.
- Cross-talk between inflammation and angiotensin II: studies based on direct transfection of cardiomyocytes with AT1R and AT2R cDNA.
- Large Impact of Low Concentration Oxidized LDL on Angiogenic Potential of Human Endothelial Cells: A Microarray Study.
- Oxidized LDL Triggers Pro-Oncogenic Signaling in Human Breast Mammary Epithelial Cells Partly via Stimulation of MiR-21.
- MicroRNA hsa-let-7g targets lectin-like oxidized low-density lipoprotein receptor-1 expression and inhibits apoptosis in human smooth muscle cells.
- Aspirin downregulates Angiotensin type 1 receptor transcription implications in capillary formation from endothelial cells.
- Cholesterol-Induced Membrane Microvesicles As Novel Carriers of Damage-Associated Molecular Patterns: Mechanisms of Formation, Action, and Detoxification.
- Prevalence of Takotsubo Cardiomyopathy in the United States.
- Delineation of the effects of angiotensin type 1 and 2 receptors on HL-1 cardiomyocyte apoptosis.
- Assessing the Credibility of the "YouTube Approach" to Health Information on Acute Myocardial Infarction.
- Comparison of Outcomes of Weekend Versus Weekday Admissions for Atrial Fibrillation.
- Seasonal variation in Hypertensive emergency hospitalization.
- Adherence junction proteins in angiogenesis: modulation by aspirin and salicylic acid.
- Dual AAV/IL-10 Plus STAT3 Anti-Inflammatory Gene Delivery Lowers Atherosclerosis in LDLR KO Mice, but without Increased Benefit.
- LOX-1, Oxidative Stress and Inflammation: A Novel Mechanism for Diabetic Cardiovascular Complications.
- Angiogenesis is a Link Between Atherosclerosis and Tumorigenesis: Role of LOX-1.
- In vivo flow cytometry of circulating clots using negative photothermal and photoacoustic contrasts.
- Oxidized LDL, LOX-1 and Atherosclerosis.
- Novel Concepts in the Genesis of Hypertension: Role of LOX-1.
- Effect of Joint National Committee VII Report on Hospitalizations for Hypertensive Emergencies in the United States.
- Do Atherosclerosis and Obesity-Associated Susceptibility to Cancer Share Causative Link to oxLDL and LOX-1?
- LOX-1 and Obesity.
- LOX-1 and Angiotensin Receptors, and Their Interplay.
- LOX-1: A Critical Player in the Genesis and Progression of Myocardial Ischemia.
- LOX-1: A New Target for Therapy for Cardiovascular Diseases.
- LOX-1 Transcription.
- Oxidized Low-Density Lipoprotein and Atherosclerosis Implications in Antioxidant Therapy.
- Determining the significance of side branch lesion during bifurcation stenting.
- Triad of metabolic syndrome, chronic kidney disease, and Coronary heart disease with a focus on microalbuminuria death by overeating.
- Oxidative Stress and Lectin-Like Ox-LDL-Receptor LOX-1 in Atherogenesis and Tumorigenesis.
- Prior Exposure to Oxidized Low Density Lipoprotein Limits Apoptosis in Subsequent Generations of Endothelial Cells by Altering Promoter Methylation.
- Angiostatic effects of aspirin in hypoxia-reoxygenation are linked to modulation of TGFβ1 signaling.
- Review of Contemporary Antiarrhythmic Drug Therapy for Maintenance of Sinus Rhythm in Atrial Fibrillation.
- Statins and renal Disease: friend or foe?
- Change in mortality from Coronary heart disease and stroke in Arkansas (1979 to 2007).
- Potential Involvement of LOX-1 in Functional Consequences of Endothelial Senescence.
- Oxidized LDL Receptor 1 (OLR1) as a Possible Link between Obesity, Dyslipidemia and Cancer.
- Role of genomics in cardiovascular medicine.
- Aspirin resistance: Fact or fiction? A point of view.
- Antiangiogenic and antimitotic effects of aspirin in hypoxia–reoxygenation modulation of the LOX-1-NADPH oxidase axis as a potential mechanism.
- Management of dyslipidemia in the elderly population.
- AAV/hSTAT3-gene delivery lowers Aortic inflammatory cell infiltration in LDLR KO mice on high cholesterol.
- Circulating endothelial progenitor cells, microparticles and vascular Disease.
- Molecular imaging of atherosclerotic plaques targeted to oxidized LDL receptor LOX-1 by SPECT/CT and magnetic resonance.
- Genomics of cardiac remodeling in angiotensin II-treated wild-type and LOX-1-deficient mice.
- Antiarrhythmic drug therapy vs catheter ablation for paroxysmal Atrial fibrillation.
- Curcumin reduces angiotensin II-mediated cardiomyocyte growth via LOX-1 inhibition.
- Racial disparities in prescriptions for cardioprotective drugs and cardiac outcomes in Veterans Affairs Hospitals.
- Rosuvastatin attenuates Ang II--mediated cardiomyocyte hypertrophy via inhibition of LOX-1.
- Cardiac hypertrophy during hypercholesterolemia and its amelioration with rosuvastatin and amlodipine.
- Statins and angiogenesis: is it about connections?
- Deletion of LOX-1 attenuates renal injury following angiotensin II infusion.
- Association of scavenger receptors in adipose tissue with insulin resistance in nondiabetic humans.
- Hemodynamically insignificant multiple internal mammary Artery graft dissections.
- Intracellular signaling of LOX-1 in endothelial cell apoptosis.
- Regression and shift in composition of Coronary atherosclerotic plaques by pioglitazone: insight from an intravascular ultrasound analysis.
- Currying the Heart: curcumin and cardioprotection.
- LOX-1 dependent overexpression of immunoglobulins in cardiomyocytes in response to angiotensin II.
- Value of CRP in Coronary risk determination.
- Modulation of angiotensin II-mediated Hypertension and cardiac remodeling by lectin-like oxidized low-density lipoprotein receptor-1 deletion.
- Regulation of TGFbeta1-mediated collagen formation by LOX-1: studies based on forced overexpression of TGFbeta1 in wild-type and lox-1 knock-out mouse cardiac fibrobla...
- Effect of statins on the development of renal dysfunction.
- Percutaneous intervention in saphenous vein bypass graft Disease: case against the use of drug-eluting stents.
- Assessment of left ventricular function: comparison of cardiac multidetector-row computed tomography with two-dimension standard echocardiography for assessment of lef...
- Over-expression of angiotensin II type 2 receptor (agtr2) decreases collagen accumulation in atherosclerotic plaque.
- Present status of Coronary bifurcation stenting.
- Anti-LOX-1 therapy in rats with diabetes and dyslipidemia: ablation of renal vascular and epithelial manifestations.
- Percutaneous intervention on the saphenous vein bypass grafts--long-term outcomes.
- Small concentrations of oxLDL induce capillary tube formation from endothelial cells via LOX-1-dependent redox-sensitive pathway.
- Angiotensin II induces capillary formation from endothelial cells via the LOX-1 dependent redox-sensitive pathway.
Procedures Preformed
- Ablation for Treatment of Cardiac Arrhythmias
- Cardiac Catheterization (incl. Coronary Angiography)
- Cardiac Imaging
- Cardiac Myocardial Perfusion Imaging
- View All
Conditions Treated
- Angina and Acute Coronary Syndrome
- Aortic Valve Disease
- Arrhythmias (incl. Atrial Fibrillation)
- Cardiomegaly
- View All
Doctors Specialties
- Cardiology
Accepted Insurances
Awards
- Elected Member
- Whos Who in Medicine and Healthcare
Education
-
North Shore-Long Island Jewish Health System -
Mount Sinai Beth Israel -
Government Medical College Amritsar
Drug Facts
| NPI NUMBER | 1225135148 | |
| NPPES Provider LastName | MEHTA | |
| NPPES Provider FirstName | JAWAHAR | |
| NPPES Provider ZIPCode | 722054024 | |
| NPPES Provider State | AR | |
| Specialty Description | Cardiology | |
| Total Claim Count | 229.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1225135148 |
| Last Name Of The Provider | MEHTA |
| First Name Of The Provider | JAWAHAR |
| View All |
Similar Doctors
|
|
Dr. Balakrishna V. Pai, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. David E. Smith, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. William A. Rollefson, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. David D. Griffin, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Donald F. Meacham, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Clayton D. Borg, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. James E. Shuffield, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Thomas A. Bruce, MD |